MU Among First Institutions to Enroll Patient in International COVID-19 Clinical Trial

Share This Story, Choose Your Platform!

The University of Missouri School of Medicine is one of the first institutions in the world to enroll a patient in a new National Institutes of Health (NIH) clinical trial designed to test the safety, tolerability and efficacy of a combination treatment for COVID-19. Read more…